-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Reiterates Overweight on Kura Oncologyto Overweight

Benzinga·06/26/2025 13:36:24
Listen to the news
Cantor Fitzgerald analyst Li Watsek reiterates Kura Oncology (NASDAQ:KURA) from Overweight to Overweight.